SILENCE
LIVE

Serial Number

87478979

Owner

SILENCE THERAPEUTICS GMBH

Attorney

Thad Chaloemtiarana

Filing Date

Jun 7, 2017

Add to watchlist:

No watchlists yet
View on USPTO

SILENCE Trademark

Serial Number: 87478979 • Registration: 5553119

SILENCE is a trademark filed by SILENCE THERAPEUTICS GMBH on June 7, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SILENCE THERAPEUTICS GMBH (6 trademarks)

ROBERT-ROSSLE-STRAßE 10
BERLIN 13125 , DE

Entity Type: 16

Trademark Details

Filing Date

June 7, 2017

Registration Date

September 4, 2018

Published for Opposition

June 19, 2018

Goods & Services

[ treatment of materials by laser beam; treatment of materials, namely, the addition of polymer additives, radio opacifiers and antimicrobial agents to render them ecogenic, radiopaque or bacteriostatic; custom manufacture of nucleic acids for third parties; custom manufacture of lipids for third parties; custom manufacture of nucleic acid containing composition for third parties; custom manufacture of transformed biological cells to the specification of third parties ]

Pharmaceutical and veterinary preparations for use in the treatment of rare diseases, namely, iron overload disorders, acromegaly, metabolic diseases, cardiovascular disease, alcohol use disorder, delayed graft function and acute kidney injury; Pharmaceutical and veterinary preparations containing a nucleic acid for use in the treatment of rare diseases, namely, iron overload disorders, acromegaly, metabolic diseases, cardiovascular disease, alcohol use disorder, delayed graft function and acute kidney injury; Pharmaceutical and veterinary preparations containing a nucleic acid for mediating RNA interference for use in the treatment of rare diseases, namely, iron overload disorders, acromegaly, metabolic diseases, cardiovascular disease, alcohol use disorder, delayed graft function and acute kidney injury; all goods mentioned before not for gynaecological pharmaceutical preparations; nucleic acid molecules for medical or veterinary use

Chemicals used in industry and science; nucleic acid molecules for laboratory use; arrays of nucleic acid molecules for scientific and medical research; nucleic acid molecules mediating RNA interference for scientific and medical research

Medical Services; veterinary services; hygienic and beauty care for human beings and animals

Scientific and technological services, namely, research and design in the fields of RNA interference and delivery of pharmaceuticals; industrial analysis and research services in the fields of biological research, molecular biology, genetics and microbiology; design and development of computer hardware and software; scientific and technological services, namely, research in the field of RNA interference and delivery of pharmaceuticals; industrial analysis and research services in the field of RNA interference and delivery of pharmaceuticals

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jun 16, 2025 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Jun 16, 2025 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 12, 2025 APRE
TEAS SECTION 8 RECEIVED
Mar 4, 2025 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 4, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Sep 4, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 19, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jun 19, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 30, 2018 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 15, 2018 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2018 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 8, 2018 ZZZX
WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST
May 8, 2018 ISMR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 8, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 8, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 18, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 4, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 4, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 4, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 4, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 4, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2018 CRFA
ASSIGNED TO LIE
Mar 28, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 14, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 14, 2017 GNRN
NON-FINAL ACTION E-MAILED
Sep 14, 2017 GNRT
NON-FINAL ACTION WRITTEN
Sep 14, 2017 CNRT
ASSIGNED TO EXAMINER
Sep 7, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 14, 2017 NWOS
NEW APPLICATION ENTERED
Jun 10, 2017 NWAP